Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery

NCT04103372 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT04103372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04103372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2024
Completion date
December 31, 2031
Enrollment
200 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer, rectal cancer